Grace Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.34

+0.09 (+4.00%)

As of May 9, 9:45 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +886.8% upside

Low Target $18.68

Average Target $23.09

High Target $33.94

Current Price $2.34

Current
$2.34

Target
$23.09

$18.68 $23.09 avg $33.94

Scenario Analysis

Bear Case

$18.68

698.3%

Low target

Base Case

$23.09

+886.8%

Avg target

Bull Case

$33.94

+1,350.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$5.18

-54.8% from high

52-Week Low

$1.79

+30.7% from low

Target vs 52W High

$23.09

+345.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	36	44%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%